Happy 4th of July to our Partners in the US!!! 🇺🇸 We celebrate the Independence Day together with You! 🎉 At Caszyme we are proud of our long term and fruitful collaborations with the US partners in developing novel CRISPR gene editing solutions and are looking forward to the future filled with mutual success! 🧬 #4thofJuly #July4th #IndependenceDay
Caszyme’s Post
More Relevant Posts
-
Director of The Medical Futurist Institute (Keynote Speaker, Researcher, Author & Futurist)
One of the most commonly asked questions about CRISPR gene editing technology revolves around its application in medicine—specifically, the reasons behind its use and the methods employed. In this video, I'll cover the basics and answer this question for you. 🙂👇
-
#Genetherapy platforming: optimizing #TFF for downstream #AAVprocessing For #viralvector-based gene therapies, TFF roles are still being established as the platform is in its early stages. Next month, join Cytiva’s Luke McCarney (Filtration Engineer) as he compares different TFF technologies for #AAVdownstreamprocessing based on format (hollow fiber and flat sheet) and membrane chemistry. He will also present data from common #AAVserotypes at various downstream steps, comparing key performance metrics such as flux, purity, and yield. Register for this #webinar below:
-
Gynaecologist | Medical education consultant | AI advocate | Researcher innovator| VR MR simulation expert | international speaker | motivator | Chair Learning and teaching champion | Member of Royal Society of medicine
1. What are the potential ethical implications and concerns associated with using CRISPR gene editing technology in medicine? 2. How can the off-target effects of CRISPR be minimized to ensure the safety and accuracy of gene editing in medical applications?
Director of The Medical Futurist Institute (Keynote Speaker, Researcher, Author & Futurist)
One of the most commonly asked questions about CRISPR gene editing technology revolves around its application in medicine—specifically, the reasons behind its use and the methods employed. In this video, I'll cover the basics and answer this question for you. 🙂👇
-
#Genetherapy platforming: optimizing #TFF for downstream #AAVprocessing For #viralvector-based gene therapies, TFF roles are still being established as the platform is in its early stages. This month, join Cytiva’s Luke McCarney (Filtration Engineer) as he compares different TFF technologies for #AAVdownstreamprocessing based on format (hollow fiber and flat sheet) and membrane chemistry. He will also present data from common #AAVserotypes at various downstream steps, comparing key performance metrics such as flux, purity, and yield. Register for this #webinar below:
Online Event
-
Tomorrow at #EAN2022, 8:30 EEST: Workshop with our coordinator Holm Graessner - he will talk about "Improving diagnosis rates in rare neurological disorders requires precision medicine and research: The Solve-RD project"
Phenotype, variant & gene queries, as well as genome-wide discoveries - all this is possible with the open access Solve-RD platform. Join our #EAN2024 workshop on June 29, 8:30 EEST with our coordinator Holm Graessner! More information: https://lnkd.in/dAfPfwP7 #rareneurologicaldisease #RND #ERNs
-
-
In a case study, Synthego and Lonza discuss their recent collaboration with Dr. Manuel Albanese and exciting results in gene editing of resting human CD4+ T cells. This case study highlights how to achieve efficient gene editing in CD4+ T cells, overcoming the traditional challenges related to cell viability and maintaining resting state. Read more here: 👇 https://lnkd.in/eRpS_adv #genomeediting #geneediting
-
-
🔍Precision in Gene Editing with NGS-Verified Engineered Cells 🧬 At EditCo Bio, accuracy is our top priority. Our engineered cell lines go through rigorous NGS verification, so you know every edit is exactly on point. Take your research to the next level with confidence and unmatched precision. Check out our latest blog on how #NGS is advancing genome engineering and how our cell lines can elevate your discoveries: https://hubs.la/Q02SX4yj0 #CRISPR #EngineeredCells #DrugDiscovery
-
-
🔬 Uncover the future of genetic research with GeneArt! 🧬 Our gene synthesis services ensure trusted quality and reliability, helping you get complex genes faster. #thermofisheremp 📩 Need help? Send me a mail to fran.apers@thermofisher.com with the topic 'LinkedIn'
GeneArt Gene Synthesis | Thermo Fisher Scientific - US
thermofisher.com
-
This is a game-changer for people with missing teeth. The potential to regrow them naturally is very exciting! 😍 Follow for more updates - GenXi - AI Updates #AI #Dental #technology #innovation #newAIupdate #genxi
💥 World's First Tooth-Regrowing Drug Enters Human Trials 💥 A revolutionary tooth-regrowing drug , targeting the USAG-1 gene, has entered human trials following successful tests in mice and ferrets. By inhibiting the USAG-1 gene, the drug stimulate tooth growth without significant side effects, offering hope to adults suffering from congenial tooth loss. #innovation #science #dentalmedicine
-
Enabling Molecular Science Success - You'll be surprised by what you can discover with our support
Sam is an excellent and engaging speaker with global experience and expertise. If you are working with or curious about characterisation of microbial content this will be will worth watching! #microbiome #microbiology #metagenomics #lifescience #learninganddevelopment #characterization #microbial #bestpractice
How can you correctly characterize microbial content when you’ve got 10,000,000,000,000 microbial cells to deal with? Start by gaining exclusive access to our specialists in metagenomics and host-microbiome studies. Learn how to reduce bias. Explore the entire process for studying gene expression in host-microbiome interactions. Two lessons in one webinar series. Register now. ➡️ https://lnkd.in/eRkPYt2m
